financetom
BSAC
financetom
/
Financials
/
BSAC
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Banco Santander-ChileBSAC
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
10.23B
Revenue (ttm)
2.11B
Net Income (ttm)
863.04M
Shares Out
188.45B
EPS (ttm)
0.00
PE Ratio
11.86
Forward PE
10.47
Dividend
$1.35 (6.07%)
Ex-Dividend Date
Apr 23, 2025
Volume
112,288
Open
21.73
Previous Close
21.67
Day's Range
21.76 - 22.33
52-Week Range
17.73 - 23.80
Beta
0.51
Analysts
Hold
Price Target
21.33 (-4.48%)
Earnings Date
May 8, 2025
Description >

Banco Santander-Chile, together with its subsidiaries, provides commercial and retail banking products and services in Chile.

It operates through Retail Banking, Middle-Market, Corporate Investment Banking, and Corporate Activities segments.

The company offers debit and credit cards, checking accounts, and savings products; consumer, automobile, commercial, mortgage, and government-guaranteed loans; and Chilean peso and foreign currency-denominated loans to finance various commercial transactions, trade, foreign currency forward contracts, and credit lines, as well as mortgage financing services.

It also provides mutual funds, insurance and securities brokerage, foreign exchange, financial leasing, factoring, financial consulting and advisory, investment management, foreign trade, treasury, and transactional services, as well as specialized services to finance residential projects.

In addition, the company offers short-term financing and fundraising, and brokerage services, as well as derivatives, securitization, and other products.

It serves individuals, small to middle-sized entities, companies, and large corporations, as well as universities, government entities, and local and regional governments.

Banco Santander-Chile was incorporated in 1977 and is headquartered in Santiago, Chile.

Latest News >
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Vanda Pharmaceuticals' Prospective Treatment for Blood Cancer Receives US FDA's Orphan Drug Designation
Dec 20, 2024
10:47 AM EST, 12/20/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) said Friday morning that the US Food and Drug Administration has designated the company's VGT-1849A product candidate as an orphan drug to treat polycythemia vera, a rare form of hematologic malignancy affecting about one in every 2,000 people in the country. The FDA uses orphan drug designation to...
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
--Netflix, FIFA Sign Broadcast Deal for Women's World Cup for 2027, 2031
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Price: 904.23, Change: +2.19, Percent Change: +0.24 ...
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Eshallgo Gets Equity Financing of up to $20 Million From CS Fund
Dec 20, 2024
10:46 AM EST, 12/20/2024 (MT Newswires) -- Eshallgo ( EHGO ) is set to receive up to $20 million in equity investment in tranches from CS Asia Opportunities Master Fund, the companies said Friday. Under their securities purchase agreement, CS Fund will buy up to about 4.2 million shares of Eshallgo ( EHGO ) at $4.80 per share in tranches,...
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Playtika, International Game Technology Partner to Bring Slots to Social Casino Games
Dec 20, 2024
10:50 AM EST, 12/20/2024 (MT Newswires) -- Playtika Holding ( PLTK ) said Friday it formed a partnership to bring some of International Game Technology's ( IGT ) slot themes to Playtika's ( PLTK ) social casino games. IGT slot titles will appear in Playtika's ( PLTK ) Slotomania, Caesars Slots, and House of Fun beginning this month and heading...
Copyright 2023-2025 - www.financetom.com All Rights Reserved